Begona Cheda-Villar
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission.
Journal: NPJ Parkinson's disease
Published: June 28, 2023
Angiotensin Type-1 Receptor Inhibition Reduces NLRP3 Inflammasome Upregulation Induced by Aging and Neurodegeneration in the Substantia Nigra of Male Rodents and Primary Mesencephalic Cultures.
Journal: Antioxidants (Basel, Switzerland)
Published: December 29, 2021
NADPH-Oxidase, Rho-Kinase and Autophagy Mediate the (Pro)renin-Induced Pro-Inflammatory Microglial Response and Enhancement of Dopaminergic Neuron Death.
Journal: Antioxidants (Basel, Switzerland)
Published: July 01, 2021
The intracellular renin-angiotensin system: Friend or foe. Some light from the dopaminergic neurons.
The intracellular renin-angiotensin system: Friend or foe. Some light from the dopaminergic neurons.
Journal: Progress in neurobiology
Published: February 28, 2020
Aging-Related Overactivity of the Angiotensin/AT1 Axis Decreases Sirtuin 3 Levels in the Substantia Nigra, Which Induces Vulnerability to Oxidative Stress and Neurodegeneration.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: August 01, 2018
Insulin-Like Growth Factor-1 and Neuroinflammation.
Journal: Frontiers in aging neuroscience
Published: September 09, 2017
The intracellular angiotensin system buffers deleterious effects of the extracellular paracrine system.
Journal: Cell death & disease
Published: March 15, 2017
Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration.
Journal: Cell death & disease
Published: June 27, 2016
Aging-related Increase in Rho Kinase Activity in the Nigral Region Is Counteracted by Physical Exercise.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: August 14, 2015
Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease.
Journal: The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry
Published: October 18, 2014
Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death.
Journal: Neuropharmacology
Published: November 25, 2013
Last Updated: 09/26/2026